Trials / Completed
CompletedNCT04443946
Different Anesthesia Maintain Protocol Effect the Outcome of the Patients
Different Anesthesia Maintain Protocol Effect the Outcome of the Patients Undergoing General Anesthesia for Urinary Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- China International Neuroscience Institution · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This prospective open-label randomized study, patients were having elective urological surgery scheduled to last longer than 1 h under necessitating general anesthesia.Group-P: (Propofol group): 3 mg kg-1 min-1 propofol was pumped continuously after endotracheal intubation. Group-PAS: (Propofol and after 20 min adding Sevoflurane group): 3 mg kg-1 min-1 propofol were pumped continuously and add 1% end-tidal sevoflurane 20 minutes after endotracheal intubation. Group-PS: (Propofol and Sevoflurane group): 3 mg kg-1 min-1 propofol were continuously pumped after endotracheal intubation, and 1% sevoflurane was inhaled continuously at the same time. Group-S: (Sevoflurane group): 1% sevoflurane continued to maintain anesthesia after endotracheal intubation. Group-PSu: (Propofol and Sufentanil group): 3 mg kg-1 min-1 propofol, 0.01 μ g kg-1 min-1 sufentanil were pumped continuously at maintain phase
Detailed description
Group-P: (Propofol group): 3 mg kg-1 min-1 propofol was pumped continuously after endotracheal intubation. Group-PAS: (Propofol and after 20 min adding Sevoflurane group): 3 mg kg-1 min-1 propofol were pumped continuously and add 1% end-tidal sevoflurane 20 minutes after endotracheal intubation. Group-PS: (Propofol and Sevoflurane group): 3 mg kg-1 min-1 propofol were continuously pumped after endotracheal intubation, and 1% sevoflurane was inhaled continuously at the same time. Group-S: (Sevoflurane group): 1% sevoflurane continued to maintain anesthesia after endotracheal intubation. Group-PSu: (Propofol and Sufentanil group): 3 mg kg-1 min-1 propofol, 0.01 μ g kg-1 min-1 sufentanil were pumped continuously at maintain phase. Due to the ethical requirements of adequent analgesia, 0.3 μ g kg-1 min-1 remifentanil was continuously pumped as background input dose during anesthesia maintenance in all groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propofol | 5 mg kg-1 h-1 propofol was pumped continuously after endotracheal intubation. |
| DRUG | 1% Sevoflurane | add 1% end-tidal sevoflurane 20 minutes after endotracheal intubation. |
| DRUG | 1% Sevoflurane continue | 1% sevoflurane continued to maintain anesthesia after endotracheal intubation. |
| DRUG | Sufentanil | 0.01 μ g kg-1 min-1 sufentanil were pumped continuously at maintain phase |
| DRUG | 2% Sevoflurane | 2% sevoflurane continued to maintain anesthesia after endotracheal intubation. |
| DRUG | Propofol half | 2.5 mg kg-1 h-1 propofol was pumped continuously after endotracheal intubation. |
Timeline
- Start date
- 2020-06-25
- Primary completion
- 2020-08-05
- Completion
- 2020-08-05
- First posted
- 2020-06-23
- Last updated
- 2020-10-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04443946. Inclusion in this directory is not an endorsement.